References
- Blum M, Demierre A, Grant DM, Heim M, Meyer UA. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proceedings of the National Academy of Sciences, USA 1991; 88: 5237–5241
- Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localization, and functional expression. DNA and Cell Biology 1990; 9: 193–203
- Deguchi T. Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. Journal of Biological Chemistry 1992; 267: 18140–18147
- Devadatta S, Gangadharam PR, Andrews RH, Fox W, Ramakrishnan CV, Selkon JB, Velu S. Peripheral neuritis due to isoniazid. Bulletin of the World Health Organisation 1960; 23: 587–598
- Ganes DA, Midha KK. Identification in in vivo acetylation pathway for N-dealkylated metabolites of doxylamine in humans. Xenobiotica 1987; 17: 993–999
- Gardner I, Bergin P, Stening P, Kenna JG, Caldwell J. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol. Chemical Research in Toxicology 1996; 9: 713–721
- Glowinski IB, Weber WW. Biochemical characterization of genetically variant aromatic amine N-acetyltransferases in A/J and C57BL/6J mice. Journal of Biological Chemistry 1982; 257: 1431–1437
- Gobry V, Bouchard G, Carrupt P-A, Testa B, Girault HH. Physicohcemical characterization of sildenafil: Ionization, lipophilicity behaviour, and ionic-partition diagram studied by two-phase titration and electrochemistry. Helvetica Chimica Acta 2000; 83: 1465–1474
- Grant DM, Blum M, Beer M, Meyer UA. Monomorphic and polymorphic human arylamine N-acetyltransferases: A comparison of liver isozymes and expressed products of two cloned genes. Molecular Pharmacology 1991; 39: 184–191
- Grant DM, Goodfellow GH, Sugamori K, Durette K. Pharmacogenetics of the human arylamine N-acetyltransferases. Pharmacology 2000; 61: 204–211
- Grant DM, Hughes NC, Janezic SA, Goodfellow GH, Chen HJ, Gaedigk A, Yu VL, Grewal R. Human acetyltransferase polymorphisms. Mutation Research 1997; 376: 61–70
- Hearse DJ, Weber WW. Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochemical Journal 1973; 132: 519–526
- Hein DW, Omichinski JG, Brewer JA, Weber WW. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. Journal of Pharmacology and Experimental Therapeutics 1982; 220: 8–15
- Hein DW, Rustan TD, Bucher KD, Furman EJ, Martin WJ. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. Journal of Pharmacology and Experimental Therapeutics 1991; 258: 232–236
- Hughes HB, Biehl JP, Jones AP, Schmidt LH. Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis. American Review of Respiratory Disease 1954; 70: 266–273
- Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 1997; 23: 3–25
- Palmer MJ, Bell AS, Fox DNA, Brown DG. Design of second generation phosphodiesterase 5 inhibitors. Current Topics in Medicinal Chemistry 2007; 7: 405–419
- Payton MA, Sim E. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): The identification of two novel allelic variants. Biochemical Pharmacology 1998; 55: 361–366
- Perry HM, Jr. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis. American Journal of Medicine 1973; 54: 58–72
- Spielberg SP. N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism. Journal of Pharmacokinetics and Biopharmaceutics 1996; 24: 509–519
- Stevens GJ, Payton M, Sim E, McQueen CA. N-acetylation of the heterocyclic amine batracylin by human liver. Drug Metabolism and Disposition 1999; 27: 966–971
- Vatsis KP, Martell KJ, Weber WW. Diverse point mutations in the human gene for polymorphic N-acetyltransferase. Proceedings of the National Academy of Sciences, USA 1991; 88: 6333–6337
- Vereczkey KJaL. Prediction of polymorphic N-acetylation of new drug candidates by correlation with human NAT-1 and NAT-2. Drug Development Research 2002; 56: 17–22
- Weber WW, Cohen SN. N-acetylation of drugs: Isolation and properties of an N-acetyltransferase from rabbit liver. Molecular Pharmacology 1967; 3: 266–273